Over-activated mTOR stimulates the NLRP3inflammasome, recruits pro-inflammatory factors, and contributes to AFpathogenesis by promoting fibrosis and altering atrial cell electrophysiology.Consequently, mTOR has emerged as a potential therapeutic target for AF, with itsinhibition potentially reducing AF incidence. This evidence concerns the gene MTOR and atrial fibrillation.